Ignite Creation Date:
2024-05-06 @ 2:32 PM
Last Modification Date:
2024-10-26 @ 1:32 PM
Study NCT ID:
NCT04342962
Status:
RECRUITING
Last Update Posted:
2022-01-10
First Post:
2020-04-09
Brief Title:
Tagraxofusp in Patients With CD123 or With BPDCN-IPh-like Acute Myeloid Leukemia
Sponsor:
Gruppo Italiano Malattie EMatologiche dellAdulto
Organization:
Gruppo Italiano Malattie EMatologiche dellAdulto
Organization Data
Organization:
Gruppo Italiano Malattie EMatologiche dellAdulto
Class:
OTHER
Study ID:
AML2020
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Gruppo Italiano Malattie EMatologiche dellAdulto
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None